Protease-Activated Receptor 4: A Critical Participator in Inflammatory Response

[1]  Dan Chen,et al.  Protease‐activated receptor 4 activation increases the expression of calcitonin gene‐related peptide mRNA and protein in dorsal root ganglion neurons , 2013, Journal of neuroscience research.

[2]  Dan Chen,et al.  Capsaicin Up-Regulates Protease-Activated Receptor-4 mRNA and Protein in Primary Cultured Dorsal Root Ganglion Neurons , 2013, Cellular and Molecular Neurobiology.

[3]  A. Arachiche,et al.  Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets , 2013, PloS one.

[4]  Li Lei,et al.  Mitogen-Activated Protein Kinase Pathways are Involved in the Upregulation of Calcitonin Gene-Related Peptide of Rat Trigeminal Ganglion After Organ Culture , 2012, Journal of Molecular Neuroscience.

[5]  J. Donnerer,et al.  Phosphorylation of ERK1/2 in Dorsal Root Ganglia following Sequential Mustard Oil and Thermal Stimulation of the Rat Hind Paw , 2011, Pharmacology.

[6]  T. Lindahl,et al.  Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets. , 2011, The Biochemical journal.

[7]  J. Tajti,et al.  Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2 , 2011, Cephalalgia : an international journal of headache.

[8]  D. Woulfe,et al.  Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets* , 2010, The Journal of Biological Chemistry.

[9]  A. Morris,et al.  A Gi‐independent mechanism mediating Akt phosphorylation in platelets , 2010, Journal of thrombosis and haemostasis : JTH.

[10]  T. Yoneda,et al.  Acid Activation of Trpv1 Leads to an Up-Regulation of Calcitonin Gene-related Peptide Expression in Dorsal Root Ganglion Neurons via the CaMK-CREB Cascade: A Potential Mechanism of Inflammatory Pain , 2010, Molecular biology of the cell.

[11]  V. Vellani,et al.  Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones , 2010, Molecular pain.

[12]  S. Bradesi.  PAR4: A new role in the modulation of visceral nociception , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  M. Steinhoff,et al.  Protease‐activated receptor‐4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[14]  F. Casanueva,et al.  Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. , 2009, Endocrine-related cancer.

[15]  F. Casanueva,et al.  c-Src Regulates Akt Signaling in Response to Ghrelin via β-Arrestin Signaling-Independent and -Dependent Mechanisms , 2009, PloS one.

[16]  J. McDougall,et al.  Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice. , 2009, Arthritis and rheumatism.

[17]  P. Wang,et al.  Increases in transient receptor potential vanilloid‐1 mRNA and protein in primary afferent neurons stimulated by protein kinase C and their possible role in neurogenic inflammation , 2009, Journal of neuroscience research.

[18]  P. Nicoletti,et al.  CGRP receptors in the control of pain and inflammation. , 2009, Current opinion in pharmacology.

[19]  S. Kunapuli,et al.  Regulation of plasmin-induced protease-activated receptor 4 activation in platelets , 2009, Platelets.

[20]  M. Nieman.  Protease Activated Receptor-4 (PAR4) Uses Anionic Residues to Interact with α-Thrombin in the Absence or Presence of PAR1. , 2008 .

[21]  P. Reitsma,et al.  TF:FVIIa‐specific activation of CREB upregulates proapoptotic proteins via protease‐activated receptor‐2 , 2008, Journal of thrombosis and haemostasis : JTH.

[22]  A. So,et al.  Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation , 2008, Arthritis research & therapy.

[23]  Xianglin Shi,et al.  Interaction between ERK and GSK3β Mediates Basic Fibroblast Growth Factor-induced Apoptosis in SK-N-MC Neuroblastoma Cells* , 2008, Journal of Biological Chemistry.

[24]  D. Woulfe,et al.  GSK3beta is a negative regulator of platelet function and thrombosis. , 2008, Blood.

[25]  M. Hollenberg,et al.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more , 2008, British journal of pharmacology.

[26]  M. Hollenberg,et al.  Proteinase-activated Receptor-2 Induces Cyclooxygenase-2 Expression through β-Catenin and Cyclic AMP-response Element-binding Protein* , 2008, Journal of Biological Chemistry.

[27]  M. Hirano,et al.  Distinct Ca2+ Requirement for NO Production between Proteinase-Activated Receptor 1 and 4 (PAR1 and PAR4) in Vascular Endothelial Cells , 2007, Journal of Pharmacology and Experimental Therapeutics.

[28]  H. Hamm,et al.  PAR1, but Not PAR4, Activates Human Platelets through a Gi/o/Phosphoinositide-3 Kinase Signaling Axis , 2007, Molecular Pharmacology.

[29]  R. Plevin,et al.  Cytokine upregulation of proteinase‐activated‐receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase β in human endothelial cells , 2007, British journal of pharmacology.

[30]  A. Malik,et al.  Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization , 2007, Proceedings of the National Academy of Sciences.

[31]  J. Trejo,et al.  Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer , 2007, Journal of Cell Science.

[32]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[33]  M. Steinhoff,et al.  Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulation , 2007, British journal of pharmacology.

[34]  H. Hamm,et al.  PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation* , 2006, Journal of Biological Chemistry.

[35]  Eric Reiter,et al.  GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling , 2006, Trends in Endocrinology & Metabolism.

[36]  C. Derian,et al.  Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis , 2006, Circulation.

[37]  D. Sommeijer,et al.  Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes , 2006, Journal of thrombosis and haemostasis : JTH.

[38]  S. Kunapuli,et al.  Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets. , 2006, Blood.

[39]  Qiong Shi,et al.  Role of β-arrestin 1 in the metastatic progression of colorectal cancer , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Dessem,et al.  Deep tissue inflammation upregulates neuropeptides and evokes nociceptive behaviors which are modulated by a neuropeptide antagonist , 2006, Pain.

[41]  M. Hollenberg,et al.  Neutrophils and the kallikrein–kinin system in proteinase‐activated receptor 4‐mediated inflammation in rodents , 2005, British journal of pharmacology.

[42]  H. Schultheiss,et al.  Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines , 2005, Circulation research.

[43]  Yi Dai,et al.  Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia , 2005, Brain Research.

[44]  P. Tipping,et al.  Reduction of arthritis severity in protease-activated receptor-deficient mice. , 2005, Arthritis and rheumatism.

[45]  L. P. de Sousa,et al.  Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. , 2005, Biochemical and biophysical research communications.

[46]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[47]  Thomas A Luger,et al.  Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. , 2005, Endocrine reviews.

[48]  M. Vizzard,et al.  Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. , 2005, The Journal of urology.

[49]  S. Steinberg.  The Cardiovascular Actions of Protease-Activated Receptors , 2005, Molecular Pharmacology.

[50]  M. Hollenberg,et al.  Proteinase‐activated receptor‐4: evaluation of tethered ligand‐derived peptides as probes for receptor function and as inflammatory agonists in vivo , 2004, British journal of pharmacology.

[51]  M. Hetman,et al.  Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. , 2004, European journal of biochemistry.

[52]  N. Bunnett,et al.  Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.

[53]  N. Vergnolle,et al.  Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon , 2004, Gut.

[54]  D. McKemy,et al.  Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. , 2003, Blood.

[55]  B. Citron,et al.  Persistent Protease-activated Receptor 4 Signaling Mediates Thrombin-induced Microglial Activation* , 2003, Journal of Biological Chemistry.

[56]  A. Sabri,et al.  Mechanisms of Protease-activated Receptor-4 Actions in Cardiomyocytes , 2003, The Journal of Biological Chemistry.

[57]  M. D'Andrea,et al.  Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder. , 2003, The American journal of pathology.

[58]  S. Coughlin,et al.  Protection against thrombosis in mice lacking PAR3. , 2002, Blood.

[59]  M. Bokarewa,et al.  Intra-articular tissue factor/factor VII complex induces chronic arthritis , 2002, Inflammation Research.

[60]  M. D'Andrea,et al.  Characterization of Thrombin-Induced Leukocyte Rolling and Adherence: A Potential Proinflammatory Role for Proteinase-Activated Receptor-41 , 2002, The Journal of Immunology.

[61]  W. Ruf,et al.  Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway , 2002, Science.

[62]  J. Baldassare,et al.  α-Thrombin Induces Rapid and Sustained Akt Phosphorylation by β-Arrestin1-dependent and -independent Mechanisms, and Only the Sustained Akt Phosphorylation Is Essential for G1 Phase Progression* , 2002, The Journal of Biological Chemistry.

[63]  C. Foster,et al.  Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. , 2002, Blood.

[64]  D. Zochodne,et al.  Proteinase‐activated receptor‐1 agonists attenuate nociception in response to noxious stimuli , 2002, British journal of pharmacology.

[65]  P. Andrade-Gordon,et al.  Participation of protease‐activated receptor‐1 in thrombin‐induced microglial activation , 2002, Journal of neurochemistry.

[66]  M. Silverberg,et al.  Pathways for bradykinin formation and inflammatory disease. , 2002, The Journal of allergy and clinical immunology.

[67]  James H Morrissey,et al.  Tissue factor as a proinflammatory agent , 2002, Arthritis Research & Therapy.

[68]  Wei Huang,et al.  Role of thrombin signalling in platelets in haemostasis and thrombosis , 2001, Nature.

[69]  J. Wallace,et al.  Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanism , 2001, British journal of pharmacology.

[70]  P. Conley,et al.  Impaired activation of murine platelets lacking Gαi2 , 2001 .

[71]  J. Potempa,et al.  Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. , 2001, Blood.

[72]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[73]  W Ruf,et al.  Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. , 2001, Blood.

[74]  K. Schrör,et al.  Evidence for functionally active protease‐activated receptor‐4 (PAR‐4) in human vascular smooth muscle cells , 2001, British journal of pharmacology.

[75]  J. Seckl,et al.  Adjuvant‐induced joint inflammation causes very rapid transcription of β‐preprotachykinin and α‐CGRP genes in innervating sensory ganglia , 2001, Journal of neurochemistry.

[76]  N. Bunnett,et al.  Evidence that PAR‐1 and PAR‐2 mediate prostanoid‐dependent contraction in isolated guinea‐pig gallbladder , 2000, British journal of pharmacology.

[77]  B. Ransom,et al.  Thrombin‐Induced Activation of Cultured Rodent Microglia , 2000, Journal of neurochemistry.

[78]  A. Kawabata,et al.  Dual modulation by thrombin of the motility of rat oesophageal muscularis mucosae via two distinct protease‐activated receptors (PARs): a novel role for PAR‐4 as opposed to PAR‐1 , 2000, British journal of pharmacology.

[79]  E. Joe,et al.  Thrombin Induces NO Release from Cultured Rat Microglia via Protein Kinase C, Mitogen-activated Protein Kinase, and NF-κB* , 2000, The Journal of Biological Chemistry.

[80]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[81]  V. Hans,et al.  Cell activation and inflammatory response following traumatic axonal injury in the rat , 2000, Neuroreport.

[82]  S. Coughlin,et al.  Structure-Function Analysis of Protease-activated Receptor 4 Tethered Ligand Peptides , 2000, The Journal of Biological Chemistry.

[83]  A. Kuliopulos,et al.  Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. , 2000, Biochemistry.

[84]  S. Coughlin,et al.  PAR3 is a cofactor for PAR4 activation by thrombin , 2000, Nature.

[85]  J. Moffatt,et al.  Protease-activated receptors: sentries for inflammation? , 2000, Trends in pharmacological sciences.

[86]  S. Coughlin,et al.  Protease-Activated Receptor 1 Mediates Thrombin-Dependent, Cell-Mediated Renal Inflammation in Crescentic Glomerulonephritis , 2000, The Journal of experimental medicine.

[87]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[88]  H. Grunicke,et al.  Novel Membrane-Targeted ERK1 and ERK2 Chimeras Which Act as Dominant Negative, Isotype-Specific Mitogen-Activated Protein Kinase Inhibitors of Ras-Raf-Mediated Transcriptional Activation of c-fos in NIH 3T3 Cells , 1999, Molecular and Cellular Biology.

[89]  C. Woolf,et al.  Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity , 1999, Nature Neuroscience.

[90]  S. Kunapuli,et al.  Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. , 1999, The Journal of biological chemistry.

[91]  A. Kawabata,et al.  Modulation by protease‐activated receptors of the rat duodenal motility in vitro: possible mechanisms underlying the evoked contraction and relaxation , 1999, British journal of pharmacology.

[92]  J. Wallace,et al.  Characterization of the inflammatory response to proteinase‐activated receptor‐2 (PAR2)‐activating peptides in the rat paw , 1999, British journal of pharmacology.

[93]  M. Hollenberg,et al.  Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2. , 1999, Canadian journal of physiology and pharmacology.

[94]  S. Coughlin,et al.  Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. , 1999, The Journal of clinical investigation.

[95]  A. Brunet,et al.  Nuclear translocation of p42/p44 mitogen‐activated protein kinase is required for growth factor‐induced gene expression and cell cycle entry , 1999, The EMBO journal.

[96]  M. Caron,et al.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.

[97]  Michael Schroeter,et al.  Inflammation and glial responses in ischemic brain lesions , 1998, Progress in Neurobiology.

[98]  Robert V Farese,et al.  A dual thrombin receptor system for platelet activation , 1998, Nature.

[99]  P. Mcgeer,et al.  The importance of inflammatory mechanisms in alzheimer disease , 1998, Experimental Gerontology.

[100]  Scott R. Presnell,et al.  Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[101]  A. Russo,et al.  Binding of Upstream Stimulatory Factor and a Cell-specific Activator to the Calcitonin/Calcitonin Gene-related Peptide Enhancer* , 1997, The Journal of Biological Chemistry.

[102]  E. Benveniste.  Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis , 1997, Journal of Molecular Medicine.

[103]  D. McDonald,et al.  Characterization of Antisera Specific to NK1, NK2, and NK3 Neurokinin Receptors and their Utilization to Localize Receptors in the Rat Gastrointestinal Tract , 1996, The Journal of Neuroscience.

[104]  C. Maggi.  Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves , 1995, Progress in Neurobiology.

[105]  J. Herbert,et al.  Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. , 1994, The Biochemical journal.

[106]  D. A. Walsh,et al.  The effects of calcitonin gene‐related peptide on formation of intra‐articular oedema by inflammatory mediators , 1992, British journal of pharmacology.

[107]  J. Blenis,et al.  Nuclear localization and regulation of erk- and rsk-encoded protein kinases , 1992, Molecular and cellular biology.

[108]  S. Coughlin,et al.  Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor , 1992, The Journal of cell biology.

[109]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[110]  H. Schaible,et al.  Sensitization of articular afferents to mechanical stimuli by bradykinin , 1989, Pflügers Archiv.

[111]  S. Snyder,et al.  Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[112]  R. Bar-Shavit,et al.  Biologic Activities of Nonenzymatic Thrombin: Elucidation of a Macrophage Interactive Domain , 1986, Seminars in thrombosis and hemostasis.

[113]  H. Schaible,et al.  Activation of fine articular afferent units by bradykinin , 1985, Brain Research.

[114]  R. Bar-Shavit,et al.  Monocyte chemotaxis: stimulation by specific exosite region in thrombin. , 1983, Science.

[115]  W. Dick,et al.  STUDIES ON THE RELATIVE EFFECTS OF PROSTAGLANDINS, BRADYKININ, 5‐HYDROXYTRYPTAMINE AND HISTAMINE ON THE SYNOVIAL MICROCIRCULATION IN DOGS , 1976, British journal of pharmacology.

[116]  A. Lykke,et al.  Increased vascular permeability induced in synovialis of the rat by histamine, serotonin and bradykinin , 1975, Experientia.

[117]  J. McDougall,et al.  Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism. , 2010, Journal of neurophysiology.

[118]  J. Benovic,et al.  beta-Arrestin1 interacts with the G-protein subunits beta1gamma2 and promotes beta1gamma2-dependent Akt signalling for NF-kappaB activation. , 2009, The Biochemical journal.

[119]  J. Baldassare,et al.  Alpha-thrombin-mediated phosphatidylinositol 3-kinase activation through release of Gbetagamma dimers from Galphaq and Galphai2. , 2004, The Journal of biological chemistry.

[120]  P. Popovich,et al.  Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. , 2000, Progress in brain research.

[121]  F. Mulè,et al.  Tachykinins mediate noncholinergic excitatory neural responses in the circular muscle of rat proximal colon. , 1998, Canadian journal of physiology and pharmacology.